1262 Immune checkpoint inhibitor-induced inflammatory arthritis is associated with cutaneous, endocrine, and gastrointestinal immune-related adverse events: a machine learning approach

Abstract

BackgroundImmune checkpoint inhibitors (ICIs) have become a pillar of cancer therapy. However, they are associated with immune-related adverse events (irAEs), which pose significant barrier to ICI usage. ICI-induced inflammatory arthritis...